Gene therapy reveals unexpected immunity to dystrophin in patients with Duchenne muscular dystrophy

An immune reaction to dystrophin, the muscle protein that is defective in patients with Duchenne muscular dystrophy, may pose a new challenge to strengthening muscles of patients with this disease, suggests a new study appearing in the October 7, 2010, issue of The New England Journal of Medicine...

Read the whole article on

More from